These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

785 related items for PubMed ID: 28209765

  • 1. Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.
    Beldhuis IE, Streng KW, Ter Maaten JM, Voors AA, van der Meer P, Rossignol P, McMurray JJ, Damman K.
    Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28209765
    [Abstract] [Full Text] [Related]

  • 2. Worsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme.
    Damman K, Solomon SD, Pfeffer MA, Swedberg K, Yusuf S, Young JB, Rouleau JL, Granger CB, McMurray JJ.
    Eur J Heart Fail; 2016 Dec; 18(12):1508-1517. PubMed ID: 27427441
    [Abstract] [Full Text] [Related]

  • 3. Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.
    Damman K, Perez AC, Anand IS, Komajda M, McKelvie RS, Zile MR, Massie B, Carson PE, McMurray JJ.
    J Am Coll Cardiol; 2014 Sep 16; 64(11):1106-13. PubMed ID: 25212644
    [Abstract] [Full Text] [Related]

  • 4. Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction.
    Clark H, Krum H, Hopper I.
    Eur J Heart Fail; 2014 Jan 16; 16(1):41-8. PubMed ID: 24453097
    [Abstract] [Full Text] [Related]

  • 5. Predictors and Prognostic Value of Worsening Renal Function During Admission in HFpEF Versus HFrEF: Data From the KorAHF (Korean Acute Heart Failure) Registry.
    Kang J, Park JJ, Cho YJ, Oh IY, Park HA, Lee SE, Kim MS, Cho HJ, Lee HY, Choi JO, Hwang KK, Kim KH, Yoo BS, Kang SM, Baek SH, Jeon ES, Kim JJ, Cho MC, Chae SC, Oh BH, Choi DJ.
    J Am Heart Assoc; 2018 Mar 13; 7(6):. PubMed ID: 29535141
    [Abstract] [Full Text] [Related]

  • 6. Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.
    Khan MS, Fonarow GC, Ahmed A, Greene SJ, Vaduganathan M, Khan H, Marti C, Gheorghiade M, Butler J.
    Circ Heart Fail; 2017 Aug 13; 10(8):. PubMed ID: 28790052
    [Abstract] [Full Text] [Related]

  • 7. Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Group of the French Society of Cardiology.
    Mewton N, Girerd N, Boffa JJ, Courivaud C, Isnard R, Juillard L, Lamblin N, Legrand M, Logeart D, Mariat C, Meune E, Sabouret P, Sebbag L, Rossignol P.
    Arch Cardiovasc Dis; 2020 Oct 13; 113(10):660-670. PubMed ID: 32660835
    [Abstract] [Full Text] [Related]

  • 8. Meta-Analysis Evaluating the Effects of Renin-Angiotensin-Aldosterone System Blockade on Outcomes of Heart Failure With Preserved Ejection Fraction.
    Kuno T, Ueyama H, Fujisaki T, Briasouli A, Takagi H, Briasoulis A.
    Am J Cardiol; 2020 Apr 15; 125(8):1187-1193. PubMed ID: 32081366
    [Abstract] [Full Text] [Related]

  • 9. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S, Thunström E, Johansson MC, Fu M.
    Int J Cardiol; 2017 Apr 01; 232():86-92. PubMed ID: 28100428
    [Abstract] [Full Text] [Related]

  • 10. Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
    Xie W, Zheng F, Song X, Zhong B, Yan L.
    Int J Cardiol; 2016 Feb 15; 205():65-71. PubMed ID: 26720043
    [Abstract] [Full Text] [Related]

  • 11. Effects of renin-angiotensin-aldosterone system inhibitors on mortality, hospitalization, and diastolic function in patients with HFpEF. A meta-analysis of 13 randomized controlled trials.
    Zhang Q, Chen Y, Liu Q, Shan Q.
    Herz; 2016 Feb 15; 41(1):76-86. PubMed ID: 26272273
    [Abstract] [Full Text] [Related]

  • 12. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure.
    Nochioka K, Sakata Y, Shimokawa H.
    Adv Exp Med Biol; 2018 Feb 15; 1067():17-30. PubMed ID: 29542073
    [Abstract] [Full Text] [Related]

  • 13. Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial.
    Redouane B, Greene SJ, Fudim M, Vaduganathan M, Ambrosy AP, Sun JL, DeVore AD, McNulty SE, Mentz RJ, Hernandez AF, Felker GM, Cooper LB, Borlaug BA, Velazquez EJ, Margulies KB, Sharma A.
    Circ Heart Fail; 2020 May 15; 13(5):e006758. PubMed ID: 32362166
    [Abstract] [Full Text] [Related]

  • 14. Impact of left ventricular ejection fraction on the effect of renin-angiotensin system blockers after an episode of acute heart failure: From the KCHF Registry.
    Yoshikawa Y, Tamaki Y, Morimoto T, Yaku H, Yamamoto E, Inuzuka Y, Ozasa N, Kitai T, Nagao K, Sato Y, Kondo H, Tamura T, Nakagawa Y, Kuwahara K, Kato T, Kimura T.
    PLoS One; 2020 May 15; 15(9):e0239100. PubMed ID: 32925953
    [Abstract] [Full Text] [Related]

  • 15. Medical Therapies for Heart Failure With Preserved Ejection Fraction.
    Kjeldsen SE, von Lueder TG, Smiseth OA, Wachtell K, Mistry N, Westheim AS, Hopper I, Julius S, Pitt B, Reid CM, Devereux RB, Zannad F.
    Hypertension; 2020 Jan 15; 75(1):23-32. PubMed ID: 31786973
    [Abstract] [Full Text] [Related]

  • 16. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L, Cinca J, Vazquez-García R, Gonzalez-Juanatey JR, Rivera M, Segovia J, Pascual-Figal D, Bover R, Worner F, Delgado-Jiménez J, Fernández-Avilés F, Martínez-Sellés M.
    Intern Med J; 2019 Dec 15; 49(12):1505-1513. PubMed ID: 30887642
    [Abstract] [Full Text] [Related]

  • 17. The effect of renin-angiotensin system inhibitors on mortality and heart failure hospitalization in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis.
    Shah RV, Desai AS, Givertz MM.
    J Card Fail; 2010 Mar 15; 16(3):260-7. PubMed ID: 20206902
    [Abstract] [Full Text] [Related]

  • 18. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.
    Weir MR, Rolfe M.
    Clin J Am Soc Nephrol; 2010 Mar 15; 5(3):531-48. PubMed ID: 20150448
    [Abstract] [Full Text] [Related]

  • 19. Renin-angiotensin-aldosterone system inhibitors in heart failure.
    Shearer F, Lang CC, Struthers AD.
    Clin Pharmacol Ther; 2013 Oct 15; 94(4):459-67. PubMed ID: 23852393
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of Renin-angiotensin-aldosterone-system inhibitors for heart failure with preserved ejection fraction and left ventricular hypertrophy -from the KUNIUMI Registry Acute Cohort.
    Odajima S, Tanaka H, Fujimoto W, Kuroda K, Yamashita S, Imanishi J, Iwasaki M, Todoroki T, Okuda M, Hayashi T, Konishi A, Shinohara M, Toh R, Hirata KI.
    J Cardiol; 2022 Jun 15; 79(6):703-710. PubMed ID: 34924235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.